# Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

> **NCT05016284** · PHASE3 · WITHDRAWN · sponsor: **Applied Biology, Inc.**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **OTHER:** JW-100
- **DRUG:** Eucrisa

## Key facts

- **NCT ID:** NCT05016284
- **Lead sponsor:** Applied Biology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-11-24
- **Primary completion:** 2022-12-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2022-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05016284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05016284, "Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05016284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*